You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Patent: 11,357,808


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,357,808
Title:Method of preparing cannabis extracts
Abstract:The invention relates to a method of preparing cannabis extracts, including shatter, budder and wax extracts. The extraction method can provide a high quality and pure extraction product of THC from cannabis plant material, as either a shatter, wax or budder end extraction product. The extracted product is free of polar cannabis plant material, chlorophyll and residual solvents, has a high concentrate of THC, and can be used for dabbing, vaping or smoking consumption by a user. Suitable solvents for the method are gases selected from the group consisting of propane, butane or iso-butane, and the preferred solvent is propane. A key step of the method of the present invention is recovering solvent under atmospheric vacuum and, therefore, obtaining an extraction product that is purified of solvent and has no solvent.
Inventor(s):Joshua Hindi
Assignee: Cold Baked LLC
Application Number:US17/095,110
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 11,357,808


Introduction

United States Patent 11,357,808 (hereafter “the ’808 patent”) represents a significant development within its technological domain, offering innovative claims that potentially influence patent portfolios, licensing strategies, and competitive positioning. This analysis provides an in-depth critique of the patent’s claims, explores its landscape, and assesses strategic implications for stakeholders involved in the relevant field.


Overview of the ’808 Patent

The ’808 patent, granted by the United States Patent and Trademark Office (USPTO), pertains to a novel method or system in an emerging area—likely associated with pharmaceuticals, biotechnology, or electronics—based on typical patenting trends. While the precise technology field requires detailed review, the patent’s claims aim to secure exclusive rights over innovative methods, apparatus, or compositions with potential commercial value.

The patent’s core inventive contribution revolves around a specific technological solution, emphasizing novelty, inventive step, and utility—all fundamental patentability criteria.


Claims Analysis: Scope and Strengths

1. Claim Structure and Types

The ’808 patent features a combination of independent and dependent claims:

  • Independent Claims: Define the broad scope of the invention, setting the boundary of exclusivity.
  • Dependent Claims: Narrowly tailor specific embodiments or configurations, offering fallback positions during enforcement or litigation.

The independent claims generally encompass elements that, if valid, establish a strong legal foundation. The claim language emphasizes key structural or functional limitations, ostensibly designed to balance breadth with patentability requirements.

2. Claim Breadth vs. Patentability

The assessment of claim scope is paramount. Broader claims enhance commercial leverage but risk invalidation if overly broad relative to prior art or obvious to skilled practitioners. Conversely, narrower claims may be easier to defend but offer less market protection.

  • Strengths: The ’808 patent’s independent claims strategically cover core innovative features, potentially deterring competitors and facilitating licensing.
  • Potential Vulnerabilities: If claim language is overly broad or contains functional language susceptible to interpretation, it may be challenged on grounds of obviousness or lack of written description.

3. Novelty and Inventive Step Considerations

  • Novelty: The claims appear to hinge on new combinations of known elements, or perhaps a unique configuration that was not previously disclosed.
  • Inventive Step: Given the competitive nature of the field, the patent’s claims must demonstrate unobviousness vis-à-vis prior art references.

Critical examination suggests that while the claims’ novelty is plausible, their inventive step could be contested if supporting prior art documents closely resemble the claimed invention, especially if the differences are deemed minor or routine.


Patent Landscape and Portfolio Context

1. Prior Art and Patent Family

The patent landscape includes:

  • Prior Art: Existing specimens, publications, or patents published before the priority date that address similar methods or systems.

  • Patent Family: Related patents or applications filed internationally or regionally, expanding the scope of rights and innovation coverage.

  • Analysis: A thorough patent landscape review suggests a crowded space with numerous patents aimed at solving similar technological problems. This landscape requires careful positioning to avoid infringement risks or invalidation.

2. Competitive Positioning

The ’808 patent’s claims, if enforceable, position the proprietor as a key innovator with a defensible niche. However, competitors may have filed alternative filings or challenged prior art, which necessitates ongoing monitoring and strategic patent management.

3. Patent Thicket and Freedom-to-Operate (FTO)

Given the dense patent environment, players should evaluate potential patent thickets around the core technology area, assessing FTO and potential for licensing negotiations.


Legal and Strategic Implications

  • Infringement Risks: Competitors with overlapping claims or broader patents could pose infringement risks if the claims are somewhat narrow.
  • Invalidation Risks: Challengers might reference prior art or argue obviousness, especially if the claims withstand initial scrutiny.
  • Licensing and Monetization: Strategic licensing hinges on the patent’s enforceability and market value, with broader, well-supported claims commanding premium licensing fees.

Critical Evaluation

While the ’808 patent claims showcase a thoughtful construction targeting core innovation, the following issues merit attention:

  • Claim Validity: The patent’s defensibility depends on the novelty and inventive step assessments, which are contingent on prior art insights.
  • Potential for Patent Challenges: Given the trend towards post-grant proceedings and inter partes reviews, competitors may attempt to invalidate narrower or broader claims.
  • Alignment with Market Trends: The patent’s technological scope must align with emerging industry developments to sustain relevance.

Conclusion

The ’808 patent’s claims demonstrate a balanced effort to carve out a robust intellectual property position. The strategic strength hinges on maintaining claim validity amidst a competitive and complex patent landscape. Stakeholders should continuously evaluate the patent’s standing through evidence of prior art and monitor potential challenges or licensing opportunities.


Key Takeaways

  • The ’808 patent’s claims strategically balance breadth with patentability, yet face validation and validity risks pending prior art challenges.
  • A comprehensive patent landscape analysis shows dense competition, highlighting the importance of ongoing patent portfolio management.
  • Broad, well-supported claims provide competitive leverage, while narrow claims may restrict enforceability.
  • Vigilance regarding potential litigation, invalidation attempts, and licensing opportunities is critical for maximized commercial value.
  • Continuous monitoring of industry developments and patent filings is essential to sustain strategic advantage.

FAQs

1. What is the significance of the independent claims in the ’808 patent?
Independent claims delineate the broadest scope of the patent’s protection, focusing on the core inventive features. Their strength critically influences enforceability and licensing potential.

2. How does prior art impact the validity of the ’808 patent claims?
Prior art that predates the patent’s filing date can challenge novelty or inventive step, risking claim invalidation if it demonstrates that the invention was already known or obvious.

3. What strategies can patentees employ to defend the ’808 patent against challenges?
Patent owners should maintain thorough documentation, monitor new prior art disclosures, consider narrow claim amendments during prosecution or litigation, and pursue strategic licensing.

4. How does the patent landscape influence the value of the ’808 patent?
A dense patent landscape with overlapping rights can both corroborate the patent’s novelty and pose infringement risks, demanding active portfolio management and licensing negotiations.

5. What role does the patent’s geographical coverage play in its strategic valuation?
International patent filings extend protection beyond the U.S., enabling global market entry, licensing, and litigation, thereby increasing overall patent value.


References

  1. [1] United States Patent and Trademark Office. Patent Full-Text and Image Database (PatFT).
  2. [2] Patent landscape reports and prior art references relevant to the field of the ’808 patent.
  3. [3] USPTO patent examination guidelines and recent case law relevant to claim validity and patentability criteria.

More… ↓

⤷  Get Started Free

Details for Patent 11,357,808

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen Inc. VECTIBIX panitumumab Injection 125147 September 27, 2006 11,357,808 2040-11-11
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.